IHS Chemical Week

World News and Views :: Top of the News

Informex 2013: Bright outlook for US API manufacturing

12:26 PM MST | February 22, 2013 | Rebecca Coons in Anaheim

Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical ingredient (API) production are moving away from low-cost emerging market firms, lifting prospects for US-based producers, according to attendees of Informex, currently underway in Anaheim, CA.  “Cost is an important factor and always will be,” said Aslam Malik, president of Ampac Fine Chemicals. “But customers are looking at other attributes, like communication, the legal system, the culture, the service...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 



Comments (1) for Informex 2013: Bright outlook for US API manufacturing
1.
If we are a barometer of economic activity signs couldn't be more positive. We have received more executive search requests from this years Informex then from the last 5 years combined. Patrick Ropella www.ropella.com
Posted by Patrick Ropella on Monday, February 25, 2013 @ 06:02 AM










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa